Omeros Corporation Reports Second Quarter 2021 Financial Results apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Omeros Announces Preliminary Results from Additional Critically Ill COVID-19 Patients Treated with Narsoplimab streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Study Patients Comprise Second Cohort from Bergamo, Italy Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing
Share this article
Share this article
COPENHAGEN, Denmark, May 25, 2021 /PRNewswire/ IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology, announced today the appointment of Muhammad Al-Hajj, PhD as Chief Scientific Officer. He will report to the CEO and be based in the Washington DC metro area, United States, where the company will establish an R&D site.
Dr. Muhammad Al-Hajj We are thrilled that Dr. Al-Hajj is joining IO Biotech at such an exciting time in the development of our company, said Mai-Britt Zocca, PhD, Chief Executive Officer, and founder of IO Biotech. He is a well-respected scientific leader with deep expertise and a proven track record in the field of immuno-oncology with expertise in translational medicine and biomarker discovery. Dr. Al-Hajj will play a pivotal role in harnessing the power of our T-win technology platform to build on our lead progr
Omeros and Quantum Leap Announce First Patients Dosed with Narsoplimab in the I-SPY COVID-19 Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.